Home›Companies›Healthcare›Upstream Metabolics

Upstream Metabolics, Inc.

No website or LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Sep 29, 2026·Suggest an edit

About Upstream Metabolics

Upstream Metabolics is a private company based in Lafayette, California, incorporated in 2026 in Delaware. It has reported $50,000 raised in one offering on Form D since September 2026. Its chief executive is Sam Thorpe.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 21, 2026Sep 29, 2026$50,000of $150K target1$50,000Simple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Upstream Metabolics's Form D filed Sep 29, 2026.

ST
Sam Thorpe
Chief Executive Officer and director
AS
Ashley Smith
Executive officer and director

Sources

  1. SECUpstream Metabolics, Inc. filing history